Search results for "EGF Receptors"

showing 10 items of 34 documents

Improved Regeneration of Autologous Nerve Transplants by Means of VEGF-Gene Therapy

2009

The impact of the Vascular Endothelial Growth Factor (VEGF) on the angiogenic cascade is proven. Recently its neuroprotective effect after peripheral nerve injuries on α-motoneurons in the spinal cord was shown. Experiments on α-motoneurons demonstrated a decreased sensitivity to ischemia under VEGF-therapy. Aim of the study was to elucidate the effect of a localized VEGF-gene-therapy using an adenoviral vector construct in the model of a peripheral nerve defect in the rat treated with an autologous nerve transplant.

Pathologymedicine.medical_specialtybiologybusiness.industryVEGF receptorsIschemiaSpinal cordmedicine.diseaseNeuroprotectionViral vectorVascular endothelial growth factorchemistry.chemical_compoundmedicine.anatomical_structurechemistryPeripheral nerveDecreased Sensitivitybiology.proteinMedicinebusiness
researchProduct

Synthesis of Triazenoazaindoles: a New Class of Triazenes with Antitumor Activity

2011

Despite improvements in the treatment and prevention of cancer, the number of new diagnoses continues to rise; this has fuelled substantial interest in the development of new and effective chemotherapeutic agents. Compounds of the triazene class, such as dacarbazine, have been used in the clinical management of many cancer types including brain, leukemia, and melanoma. A new compound class bearing a triazenoazaindole scaffold was synthesized with the aim of identifying new antiproliferative agents. Compounds 5 a-g and 6 a-c were screened against a panel of human tumor cell lines, and two of them, 5 e and 5 f, showed cytotoxicity (GI(50) range: 2.2-8.2 μM) in all cell lines. These two compou…

Programmed cell deathIndolesToxicology and Pharmaceutics (all)DacarbazineAntineoplastic AgentsAntiproliferative activityPharmacologyEGF receptorsDrug Screening AssaysBiochemistryCell LineFlow cytometryCell Line TumorNeoplasmsDrug DiscoveryTriazenoazaindolemedicineHumansTriazeno derivativesGeneral Pharmacology Toxicology and PharmaceuticsCytotoxicityPharmacologyAntitumor agentsTumorEpidermal Growth Factormedicine.diagnostic_testChemistryMelanomaOrganic ChemistryCancerAntitumorTriazenoazaindoles; Dacarbazine; Antitumor Activitymedicine.diseaseErbB ReceptorsDacarbazineApoptosisCell cultureMolecular MedicineDrug Screening Assays AntitumorAntitumor ActivityTriazenesTriazenoazaindolesAntiproliferative activity; Antitumor agents; EGF receptors; Triazeno derivatives; Antineoplastic Agents; Cell Line Tumor; Dacarbazine; Drug Screening Assays Antitumor; Humans; Indoles; Neoplasms; Receptor Epidermal Growth Factor; Triazenes; Pharmacology Toxicology and Pharmaceutics (all); Organic Chemistry; Molecular MedicineReceptormedicine.drugChemMedChem
researchProduct

Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF…

2012

e14676 Background: HCC accounts for approximately 90% of all primary liver cancers, and is the fifth most common cancer in the world and prognosis is so far very poor,particularly in E patients.Between all tentative of treatment till know SFB seems to be the most promising drug in patients with advanced or metastatic HCC.Aim of the study is to investigate if SFB is efficient and safe also in E HCC patients despite the comorbidities and other problems. Objectives: To investigate if CgA and VEGF work as predicting factors of Sorafenib treatment outcomes. Methods: 51 patients, mean age 68,9 (65-85) with HCC were enrolled . Serum CgA, VEGF and αFP were evaluated at baseline and after end of tr…

SorafenibOncologyCancer ResearchPathologymedicine.medical_specialtybiologybusiness.industryVEGF receptorsTreatment outcomeCancermedicine.diseaseVascular endothelial growth factorchemistry.chemical_compoundOncologychemistryGeriatric oncologyHepatocellular carcinomaInternal medicinemedicinebiology.proteinbusinessgeriatric oncologymedicine.drug
researchProduct

Ratios between VEGF ligands and receptors in tumor and stroma have impact on the outcome in resectable NSCLC.

2013

e22147 Background: In tumor angiogenesis there is a complex interplay between endothelial, stromal and tumor cells. Some key regulators of this process are the members of the vascular endothelial growth factor (VEGF) family of ligands and receptors and the neuropilins (NRP). This study analyzes the correlations between the expression of these angiogenic factors in tumor cells and tumor stroma, and their prognostic role in tissue samples from resected non-small cell lung cancer (NSCLC) patients. Methods: Representative tumor and stroma areas from FFPE tissue samples of 125 early-stage NSCLC patients were carefully micro-dissected. RNA isolated from the samples was retrotranscripted and prea…

Tumor angiogenesisCancer ResearchStromal cellbiologybusiness.industryVEGF receptorsTumor cellsOncologyStromabiology.proteinCancer researchMedicinebusinessReceptorJournal of Clinical Oncology
researchProduct

Co-activation of VEGF and NMDA receptors promotes synaptic targeting of AMPA receptors

2016

Vascular Endothelial Growth Factor A0301 basic medicineVEGF receptorsAMPA receptorHippocampusReceptors N-Methyl-D-Aspartate030226 pharmacology & pharmacy03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineAnimalsDementiaReceptorMolecular BiologyNeuronsbiologyChemistrySynapsinsmedicine.diseasePsychiatry and Mental health030104 developmental biologySchizophreniaSynapsesBehavioral medicinebiology.proteinNMDA receptorPsychopharmacologyDisks Large Homolog 4 ProteinNeuroscienceMolecular Psychiatry
researchProduct

Vascular endothelial growth factor gene polymorphisms in ovarian cancer

2007

Abstract Background. Polymorphisms within the vascular endothelial growth factor (VEGF) gene, the most important regulator of angiogenesis and vascular permeability, were shown to be independently associated with an impaired prognosis in various malignancies. No data have been reported in ovarian cancer. Methods. In the present multi-center study, we examined three common polymorphisms within the VEGF gene ( VEGF +405G/C, VEGF −460C/T, and VEGF +936C/T) in 553 Caucasian patients with ovarian cancer using pyrosequencing. Results. The three investigated polymorphisms did not correlate with any of the investigated clinico-pathological parameters. In univariate and multivariate models, only FIG…

Vascular Endothelial Growth Factor AGenotypeAngiogenesisVEGF receptorsRegulatorVascular permeabilityLinkage Disequilibriumchemistry.chemical_compoundHumansMedicineGeneAgedNeoplasm StagingOvarian NeoplasmsPolymorphism GeneticNeovascularization Pathologicbiologybusiness.industryHaplotypeObstetrics and GynecologyMiddle AgedPrognosismedicine.diseaseVascular endothelial growth factorOncologychemistryCancer researchbiology.proteinFemalebusinessOvarian cancerGynecologic Oncology
researchProduct

Priming with a Combination of Proangiogenic Growth Factors Enhances Wound Healing in Streptozotocin-Induced Diabetes in Mice

2010

<i>Background:</i> Numerous proangiogenic growth factors have been shown to improve impaired wound healing. This study evaluated the effects of subcutaneous pretreatment with a combination of proangiogenic growth factors on wound closure, mechanical properties, vessel density, and morphology. <i>Methods:</i> Thirty-six Balb/c mice with streptozotocin-induced diabetes were divided into 3 groups. A mixture of VEGF (35.0 µg), bFGF (2.5 µg), and PDGF (3.5 µg) was administered subcutaneously 3, 5, and 7 days prior to wounding in the first group, whereas the second group received three doses of 3.5 µg PDGF. Wound sizes were assessed daily and the repaired tissues were harv…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyVEGF receptorsNeovascularization PhysiologicPriming (immunology)PharmacologyDiabetes Mellitus ExperimentalDiabetes ComplicationsMiceTensile StrengthDiabetes mellitusAnimalsMedicineAngiogenic ProteinsSkinPlatelet-Derived Growth FactorMice Inbred BALB CWound Healingbiologybusiness.industrymedicine.diseaseStreptozotocinSurgeryWound areaDiabetic wound healingbiology.proteinFemaleFibroblast Growth Factor 2SurgeryCollagenSkin TemperaturebusinessWound healingPlatelet-derived growth factor receptormedicine.drugEuropean Surgical Research
researchProduct

Boron Ions: Simultaneous Boron Ion‐Channel/Growth Factor Receptor Activation for Enhanced Vascularization (Adv. Biosys. 1/2019)

2019

biologyChemistryVEGF receptorsIntegrinBiomedical Engineeringchemistry.chemical_elementGeneral Biochemistry Genetics and Molecular BiologyIonBiomaterialsFibronectinGrowth factor receptorbiology.proteinBiophysicsBoronIon channelAdvanced Biosystems
researchProduct

Magnetofection of acoustically active „magnetic microspheres“ (Magnetobubbles) — Induction of angiogenesis via non-viral transfection of VEGF

2009

Adenoviral transduction of the VEGF gene in an oversized skin flap increases flap survival and perfusion. In this study we investigated the potential of magnetofection of magnetic lipospheres containing VEGF165-cDNA on survival and perfusion of ischemic skin flaps and evaluated the method with respect to the significance of applied magnetic field and ultrasound.

integumentary systembiologybusiness.industryChemistryAngiogenesisVEGF receptorsUltrasoundSkin flapequipment and suppliesNon viral transfectioneye diseasesMicrospherebiology.proteinMagnetofectionCancer researchbusinesshuman activitiesPerfusion
researchProduct

Abnormal Nailfold Capillaries in Patients after Hand Transplantation

2020

Background: The development of graft vasculopathy may play a role in the long-term deterioration of hand grafts. The aim of study was to examine the patterns of the nailfold capillaries in hand transplant recipients. Methods: the study was performed on six patients who received hand transplantation. To normalize for the effect of immunosuppression an age- and sex-matched group of 12 patients with active kidney transplant was selected. As an additional control group, 12 healthy volunteers were recruited. Nailfold videocapillaroscopy was performed in all participants. Additionally, serum concentrations of vascular endothelial growth factor (VEGF) were measured. Results: Videocapillaroscopic e…

medicine.medical_specialtyAngiogenesismedicine.medical_treatmentVEGF receptorsUrologymicrovascular abnormalitieslcsh:Medicinenailfold capillaroscopy030230 surgeryArticle03 medical and health scienceschemistry.chemical_compoundangiogenesis0302 clinical medicineHealthy volunteersmedicineIn patient030203 arthritis & rheumatologybiologyvascular endothelial growth factorbusiness.industrylcsh:RImmunosuppressionGeneral MedicineSerum concentrationVascular endothelial growth factorsurgical procedures operativechemistrybiology.proteinbusinessHand transplantationhand transplantationJournal of Clinical Medicine
researchProduct